#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Anti-neutrophil cytoplasmic antibody positive vasculitis Hepatocellular carcinoma Anal cancer Fibrous dysplasia of bone Undifferentiated sarcoma Squamous cell carcinoma of the vulva Immune thrombocytopenia Biotinidase deficiency Salivary gland cancer Metastases to central nervous system Immune-mediated myasthenia gravis Neuroendocrine carcinoma of the skin Familial hypertriglyceridaemia Conjunctivitis allergic Extra-osseous Ewing's sarcoma More trials…

    Learn about Rare Diseases

    Thrombotic thrombocytopenic purpura – Basic Information Idiopathic pulmonary fibrosis – Trials in Disease Primary mediastinal large B-cell lymphoma – Basic Information Lennox-Gastaut syndrome – Basic Information Chondrosarcoma metastatic – Treatment Leiomyosarcoma metastatic – Treatment X-linked lymphoproliferative syndrome – Trials in Disease Angiosarcoma metastatic – Basic Information X-linked lymphoproliferative syndrome – Treatment Congenital hypotransferrinaemia – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Regn7075 Resiquimod Sulfate Mosaic Hbcoreag Rhh646 Trientine Dihydrochloride Ursodeoxycholic Acid Ezabenlimab Farletuzumab Ecteribulin Omalizumab Aluminium Hydroxide [18F]CPFPX IMMUNOSTEM Atomoxetine Recombinant Interferon Beta-1B Alendronic Acid Dexibuprofen Antipsychotics Sparsentan Evx-01 Ofloxacin More therapies…

    Learn about Your Condition

    External cephalic version HER2 positive breast cancer Antithrombin III deficiency Pancreatitis relapsing Persistent depressive disorder Infant sedation Mixed-type liposarcoma Haemodynamic instability Pseudomyxoma peritonei Uterine leiomyoma Pleural mesothelioma malignant Stevens-Johnson syndrome Adenocarcinoma pancreas Adenocarcinoma of colon Polymyalgia rheumatica More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of Dostarlimab and Drug Combination for Patients with Untreated Resectable Colon Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Adenocarcinoma of colon
    Investigated Drugs:
    • Capecitabine
    • Dostarlimab
    • Fluorouracil
    Belgium Czechia Estonia Finland France Germany +8

  • Study on the Effects of Sirolimus and Drug Combination for Children Under 4 Months with Tuberous Sclerosis Complex

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Tuberous sclerosis complex
    Investigated Drugs:
    • Carbamazepine
    • Oxcarbazepine
    • Phenobarbital
    Austria Germany

  • Study on Long-Term Safety of mRNA-3705 for Patients with Methylmalonic Acidemia (MMA)

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Fexofenadine Hydrochloride
    • Hydroxyzine Hydrochloride
    • Modified Mrna Encoding Human Methylmalonyl-Coenzyme A Mutase Containing A Polymorphism At Position 671
    France The Netherlands Spain

  • Study on Vitamin D Deficiency Treatment in Obese Children and Adolescents Using Colecalciferol: Comparing Monthly Boluses and Daily Doses

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Obesity
    Investigated Drugs:
    • Colecalciferol
    France

  • Study on High-Risk Prostate Cancer Treatment Using Darolutamide, Relugolix, and Drug Combination for Eligible Patients

    Recruiting

    4 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • Triptorelin
    • Degarelix
    • Leuprorelin Acetate
    Belgium Spain

  • Study on Tucatinib, Capecitabine, and Trastuzumab for Patients with HER2-Positive Breast Cancer and Leptomeningeal Metastases

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Breast cancer
    Investigated Drugs:
    • Tucatinib
    • Capecitabine
    • Trastuzumab
    France
Previous Page
1 … 533 534 535 536 537 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!